BRUSSELS (Reuters) - Belgian pharma group UCB said on Monday that U.S. health authorities had approved epilepsy drug Keppra XR and that it would go on sale just before its mother drug loses patent ...

MORRISTOWN, N.J. — Actavis has launched its version of an epilepsy drug made by UCB. The generic drug maker said it received approval from the Food and Drug Administration for levetiracetam ...

MORRISTOWN, N.J., Sept. 15, 2011 /PRNewswire/ -- Actavis, an international generic pharmaceutical company, today announced that it has received FDA approval of Levetiracetam Extended-Release Tablets, ...

Levetiracetam 100mg/mL; grape flavor; dye-free. Swallow tabs whole. Partial onset: ≥16yrs: initially 500mg twice daily. May increase at 2-week intervals in increments of 1g/day; max 3g/day. Myoclonic: ...

Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals ...

MUMBAI, Jan 16 (Reuters) - Indian drug maker Lupin said on Friday it has received final U.S. Food and Drug Administration approval to sell the generic levetiracetam tablet in multiple strengths. The ...

Levetiracetam 100mg/mL; IV infusion after dilution. Infuse over 15mins. Partial onset: ≥16yrs: initially 500mg twice daily; may increase at 2-week intervals in increments of 1g/day; max 3g/day.

Sun Pharma announced that USFDA has granted an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Keppra Injection, levetiracetam injection. This generic ...

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Q. I have epilepsy and was well-controlled on Keppra and Topamax for years. When I was switched to generic Keppra (levetiracetam) ...

Levetiracetam, the most commonly prescribed drug for U.S. infants with epilepsy, may be significantly more effective than the second-choice drug phenobarbital, according to a new study by scientists ...

Scientists at the Gladstone Institutes have discovered that an FDA-approved anti-epileptic drug reverses memory loss and alleviates other Alzheimer's-related impairments in an animal model of the ...

The patent cliff is coming early for some drugmakers. Fortunately, Glaxo is a big company. With more than $41 billion in revenue over the last 12 months, it can afford to lose a few blockbusters ...